Dalotuzumab (Anti-IGF1R / CD221)

Dalotuzumab (Anti-IGF1R / CD221) is a recombinant humanized monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF1R) with potential antineoplastic activity. MW : 146.78 KD.

• Supplier: Selleck Chemicals
• Product #: A2815
• Sku #: A2815-1mg